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ABSTRACT
Because of the emergence of multi-drug resistance bacteria and fungi, 
alternatives to conventional antimicrobial therapy are needed. This 
study aims to evaluate in vitro the antimicrobial activity of: Mirtus 
communis, Coriandrum sativum, Pelargonium capitatum, Cuminum 
cyminum, Ocimum basilicum, Citrus aurantium amara, Cymbopogon 
winterianus, Cymbopogon martini, Salvia sclarea, Melaleuca alternifolia 
and Mentha suaveolens essential oils on bacteria and fungi, in relation 
to their chemical composition. The potential interaction of M. 
alternifolia (TTO), C. sativum (CDO) and M. suaveolens (EOMS) essential 
oils when used in combination with gentamicin and fluconazole has 
been evaluated. The results obtained showed a synergic effect on some 
bacteria and fungi, with FICI values ≤5. The cytotoxicity of TTO, CDO and 
EOMS was investigated towards HeLa cells. Only EOMS did not result 
cytotoxic at the active concentrations on micro-organisms. Further 
studies are necessary to obtain optimal ratios and dosing regimens 
for higher therapeutic efficacy and to decrease toxicological profiles.
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2  F. SCAzzOCCHIO ET AL.
1. Introduction
Plant-derived compounds are always a source of novel therapeutics. Plants are known to 
produce an enormous variety of small molecules (MW <500 kDa) known as phytoalexins such 
as terpenoids, glycosteroids, flavonoids and polyphenols. Most of these small molecules have 
weak antimicrobial activity, several orders of magnitude less than that of common antibiotics 
produced by bacteria and fungi. In spite of the fact that plant-derived antibacterials are less 
potent (Seow et al. 2014), plants fight infections successfully. Aromatic and medicinal plants 
also produce a wide variety of volatile aliphatic and cyclic hydrocarbons, corresponding oxy-
genated isoprenoid derivatives and analogues that form complex mixtures called essential 
oils (Hammer et al. 1999; Rios & Recio 2005). Essential oils are a rich source of biologically 
active compounds; they were shown to possess antibacterial, antifungal, antiviral, insecticidal 
and antioxidant properties (Solorzano-Santos & Mirandas-Novales 2012). Some oils have 
also been used in cancer treatment (Gautam et al. 2014) in food preservation, aromatherapy 
and fragrance industry. Because of all these properties, medicinal and aromatic plants which 
and constitute a major source of important organic compounds (Gurib-Fakim 2006) and 
World Health Organization noted that the majority of world’s population depends on tradi-
tional medicine for primary healthcare. Commercially available essential oils from aromatic 
plants such as Melaleuca alternifolia (tea tree oil), Thymus vulgaris (Thyme), Mentha piperita 
(Peppermint), Rosmarinus officinalis (Rosemary), Citrus aurantium (Lime oil) and Cymbopogon 
martini (Palmarosa oil) have been extensively used for the treatment of topical bacterial 
(Prabuseenivasan et al. 2006) and fungal infections. Indeed, Coriandrum sativum has been 
recommended for dyspeptic complaints, loss of appetite, convulsion, insomnia and anxiety 
(Emamghoreishi et al. 2005) in addition to its antimicrobial activity (Silva et al. 2011). Also, 
essential oils from Cuminum cyminum (cumin) (Iacobellis et al. 2005), Ocimum basilicum (basil) 
(Hussain et al. 2008), Mirtus communis (myrtle) (Ragno et al. 2008) are known for antimicrobial 
and antioxidant properties. Gram positive and negative bacteria, in addition to fungi, are 
responsible for several human infections. Effective antimicrobials have been developed over 
the years; however, it has been observed a dramatic increase in resistance to antimicrobial 
drugs. Although antibiotics have been effective to fight infectious diseases for a long time, 
resistance to these drugs has also led to the reemergence of old infectious diseases. For this 
reason, the development of new antimicrobial compounds appears necessary. Actually, one 
strategy employed to overcome resistance mechanisms has been the use of combinations of 
drugs, such as beta-lactams together with beta-lactamase inhibitors or combinations of dif-
ferent classes of drugs (Rey-Jurado et al. 2013). Medicinal plants and herbs represent preferred 
sources of active molecules which could become lead compounds for new pharmaceutical 
products. Moreover, several plant extracts exhibited ‘in vitro’ synergic activity when utilised 
in combination with different drugs against several micro-organisms and could represent 
a new alternative approach to infectious diseases treatment. Further studies are necessary 
to better define cytotoxicity of EOs, since in literature, a data reported mainly the effect on 
tumoral cell lines. (Elsayed et al. 2015).This article reports the antimicrobial screening of 
eleven essential oils against some bacterial and fungal species, the interaction of C. sativum, 
M. alternifolia and Mentha suaveolens EOs with conventional antimicrobial drugs such as 
gentamicin or fluconazole and toxicity studies towards a cell line of human origin (HeLa).
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NATuRAL PRODuCT RESEARCH  3
2. Results and discussion
2.1. Antimicrobial activity of essential oils by diffusion test
The antimicrobial activity of eleven EOs measured by diffusion test against selected species 
of bacteria and fungi is summarised in Table S1. The results reveal that EOs show antimicro-
bial activity with varying magnitudes and specie specificity. The zone of growth inhibition 
above 8 mm in diameter was taken as a positive result. Generally, most of the tested micro-
 organisms were sensitive to many of the EOs. At a concentration of 20 mg/ml, the best activity 
has been expressed by M. alternifolia, M. communis, C. sativum, C. cyminum, Cymbopogon 
winteranius and M. suaveolens EOs, with inhibition halos between 33.7 and 10.4 mm diameter 
for gram-positive or gram-negative bacteria and between 70 and 12 mm for fungi. In par-
ticular, M. alternifolia, Coriandrum sativum and M. communis EOs produced inhibition halos 
between 17 and 33.7 mm, or between 18.4 and 25 mm against Staphylococcus epidermidis 
strains and Staphylococcus aureus ATCC 25923, respectively. In the case of gram-negative 
bacteria, inhibition halos ranged between 17 and 29.4 mm, 29–30 mm, 23.5 and 29.5 mm 
for the multi-resistant clinical isolate of Klebsiella pneumoniae, Acinetobacter baumanii and 
Escherichia coli ATCC 25922, respectively. Moreover, the same oils showed a strong activity 
towards Candida albicans strains with inhibition halos between 30 and 60 mm. M. suaveolens, 
C. cyminum and C. winteranius showed a lower antibacterial activity with inhibition halos 
ranging from 13.5 to 19.6 mm for all tested bacteria, while they resulted active towards 
fungi with inhibition halos between 20 and 40 mm. The observed variability in sensitivity 
might be due to the different chemical composition of each essential oil and to the kind 
of micro-organism tested. These differences could also be referred to a different rate of 
essential oils constituent’s penetration through the cell wall and cell membrane structures. 
For example, the antibacterial properties of tea tree oil (TTO) have been attributed to the 
monoterpenoid, terpinen-4-ol. Because of its lipophilic nature, it is thought to diffuse into 
and damage cell membrane structures, or to inhibit membrane-bound enzymes (zengin & 
Baysal 2014). Linalool, which is the main constituent in C. sativum EO, is known to bind to 
membrane ergosterol, increasing ionic permeability and causing membrane damage leading 
to cell death. Linalool is inactive (Freires et al. 2014) on cell wall biosynthesis-related path-
ways. The ability of essential oils to disrupt the permeability barrier of the cell membrane 
structures and the accompanying loss of chemiosmotic control are the most likely reasons 
for their lethal action. The active concentrations of oils were generally about 100 times 
higher than those of gentamicin or fluconazole. This difference could be explained taking 
into account that essential oils are complex mixtures of different compounds, where only 
some molecules could have antimicrobial properties. Identification and purification of the 
different components could highlight the most active antimicrobial molecules.
2.2. Chemical composition of essential oils
Taking into account the chemical composition of the EOs reported in Table 1, their activity 
towards gram-positive or gram-negative bacteria and fungi could be related to the functional 
group that characterises the main component. Nevertheless, it has to be considered that 
the presence of minor components might also play a role to determine such an effect. The 
antibacterial and antifungal activity of C. aurantium amara essential oil could be attributed 
to the presence of limonene, a monoterpene that represents 90.7% of the total extract. The 
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6  F. SCAzzOCCHIO ET AL.
antimicrobial activity described is in agreement with literature data (Viuda-Martos et al. 2008; 
ulukanli et al. 2014). C. winteranius and C. cyminum essential oils are both active against fungi. 
The antifungal activity of these extracts can be ascribed to the two aldehydes representing 
the main components: cuminal (49.6%) for C. cyminum and β-citronellal (41.8%) for C. win-
teranius. Cuminal, an uncommon aldehyde, is present in Eucalyptus camaldulensis essential 
oils from Sardinia, which is known for antifungal activity towards common phytopathogenic 
fungi (Barra et al. 2010). A main component with alcoholic function characterises C. sativum, 
C. martini, P. capitatum and M. alternifolia essential oils; in particular, β-citronellol, the main 
component of P. capitatum (58.8%), may be responsible for the antifungal activity of this 
essential oil, whereas terpinen-4-ol, geraniol and linalool which are the main components of 
M. alternifolia (53.7%), C. martini, (83.9%) and C. sativum (48.4%), respectively, could account 
for the antibacterial activity showed by these extracts. O. basilicum essential oil is the only 
extract characterised by an ether as a main component: estragole, representing 91.1% of 
this oil. It is partially active against gram-positive bacteria and fungi. Regard to this compo-
nent, literature data show different biological activities, in particular, it is known to increase 
phagocytic activity of macrophages (Silva-Comar et al. 2014). The observed antifungal and 
antibacterial activity of M. suaveolens essential oil utilised in this study could be attributed, 
at least partially to piperitenone, a ketone oxide that represents 38.1% of extract. It must 
be observed that in other extracts of M. suaveolens, EOs piperitenone oxide was about 90% 
(Angiolella et al. 2010). This fact can be attributed to the different plant cultivation zone in 
agreement with Khaoukha et al. (2014) and to the seasonal variations of the active constitu-
ents (Settanni et al. 2014). In the tested extract, other components are limonene 9.1%, linalool 
7.8%, and other minor chemical constituents. M. communis essential oil is active versus fungi 
and gram-negative bacteria. This oil contains as main component eucalyptol, a monoterpene 
oxide representing 36.4% of the total extract, in agreement with Akin et al. (2010), and also 
other constituents such as myrtenyl acetate, a terpene ester 31.8%, limonene and alpha-
pinene about 10%. As to, S. sclarea essential oil tested in this work, it is not characterised by 
a main component but contains more than ten different molecules with a percentage that 
never exceeds 20%, except for caryophyllene 25.8% and α-caryophyllene 22.4%. In our study, 
this oil demonstrated only poor antibacterial and antifungal activity (Table S1). On the con-
trary, low percentages of borneol and α-pinene in Ampelopsis megalophylla as reported by 
Xie et al. (2014) and caryophyllene (Joycharat et al. 2014) show high microbiological activity.
2.3. Minimal inhibitory concentration, FICI index and toxicity
Table S2 shows the minimal inhibitory concentration (MIC) values of tree essential oils 
M. alternifolia (TTO), C. sativum (CDO) and M. suaveolens (EOMS) towards bacteria and fungi 
in comparison with those obtained for gentamicin and fluconazole, respectively, used as 
reference antimicrobials. High resistance gentamicin values with MIC ≥ 64 μg/ml were high-
lighted for clinical isolated strains of S. epidermidis and A. baumanii, while for K. pneumoniae 
strains MIC values were in a range of 2–8  μg/ml; C. albicans CO23RFLu strain showed a 
fluconazole MIC value ≥ 64 μg/ml (Table S2). For gram-positive bacteria, TTO and CDO MIC 
values resulted between 6.25 and 25 mg/ml while for EOMS MIC value was 0.19 mg/ml for 
 S. aureus (Table S2). For gram-negative bacteria, MIC values ranged between 1.56 and 25 mg/
ml for TTO and CDO, respectively, while those for EOMS were about 3.12–6.25 mg/ml; for 
C. albicans strains, EOMS MIC values of 0.78 mg/ml indicated a better activity than CDO and 
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TTO which exhibited MIC values of 3.12 mg/ml. Altogether these results are in agreement 
with the high variability of the antimicrobial activity of EOs observed with the disc diffusion 
method. All EOs MIC values were in the order of magnitude of milligrams and therefore signif-
icantly higher than those obtained with the reference antimicrobial drugs. The combination 
of antimicrobials with EOs could represent a possible alternative strategy to increase the 
efficacy of antibacterial and antifungal drugs. A clear synergic effect of essential oils with 
fluconazole has been reported against C. albicans (Stringaro et al. 2014) and with different 
antibacterial substances towards gram-negative bacteria (Toroglu 2007, 2011). FICI values 
reported in Table 2 indicate a positive interaction between gentamicin and fluconazole 
with TTO, CDO and EOMS against all bacteria and fungi tested, respectively. In particular, 
a synergic effect was observed for TTO plus gentamicin towards S. aureus ATCC 25923, 
S. epidermidis, A. baumanii and for TTO plus fluconazole for C. albicans with FICI values = 0.5. 
For C. albicans ATCC 24433 and other bacterial strains, the combination TTO-antimicrobial 
drugs was found to be additive with FICI value >0.5. An additive effect was also reported for 
CDO plus gentamicin against all bacteria obtained strains tested, except for A. baumanii with 
FICI value = 0.25, in agreement with data of Duarte et al. (2012). Interestingly, the combina-
tion of fluconazole and CDO showed a synergic effect towards fungi with FICI values = 0.5. 
Also, FICI values of 0.13 and 0.37 for C. albicans CO23RFLu and CO23 strains respectively, 
obtained with EOMS plus fluconazole, indicated a strong synergic effect. In the case of bacte-
ria, EOMS plus gentamicin produced a prevalent additive effect; only for K. pneumoniae, the 
action was synergic with FICI value = 0.5. Therefore, in the case of fungi, all tested combina-
tions of EOs plus fluconazole produced a synergic effect, except for C. albicans ATCC 24433. 
On the contrary, in the case of tested bacterial strains, the effect of EOs plus gentamicin was 
mainly additive, although it has been observed even towards multi-drug resistant strains. 
However, it must be observed that EOs concentrations necessary to decrease MIC values of 
gentamicin or fluconazole appear very high and therefore probably toxic for therapeutic 
purposes. To address this issue, TTO, CDO and EOMS were evaluated for their cytotoxicity 
towards an epithelial cell line of human origin (HeLa), utilised as a model. Cell monolayers 
were exposed to EOs diluted in cell culture medium for the same time length as for antimicro-
bial testing. The values of the maximum non-cytotoxic concentration (MNCC) were 1.6 mg/ml 
for both CDO and EOMS and 0.4 mg/ml for TTO. Comparison of data obtained between EOs 
cytotoxicity studies and MIC values of antimicrobial activity for bacteria and fungi, point out 
that TTO and CDO result cytotoxic in this cell model. Only EOMS was found not to be toxic 
for HeLa cell cultures at the MIC values for fungi and gram-positive bacteria. Interestingly, 
MICs values obtained for EOMS in combination with gentamicin or fluconazole (Table 2) 
were comparable to those of MNCC for eukaryotic cells. Also, the combination of reference 
antimicrobials with CDO produced similar results on gram-positive bacteria and fungi while 
in the case of gram-negative bacteria a major variability has been observed. For TTO, all MIC 
values were always higher than MNCC values for eukaryotic cells. As reported by Reichlinga 
et al. (2009), essential oils may exert cytotoxic effects to tissue cells at concentrations which 
do not yet show an antimicrobial effect. In addition, their use could also be limited by the 
concentrations that they can achieve at the site of action. Correlations studies of in vitro 
and in vivo toxicity data are necessary in order to develop models that allow a prediction of 
systemic toxicity in vivo from cell culture data.
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3. Conclusions
Data reported in this study suggest that the antifungal and antibacterial activity of EOs 
could be related to their main chemical components. Some EOs can show an additive 
or synergic antimicrobial effect when tested in combination with sub-inhibitory concen-
trations of gentamicin or fluconazole, even against clinical multi-drug resistant isolates. 
Although results are encouraging, further studies are necessary to define the main active 
constituents of each oil and the optimal ratio between EOs and reference antimicrobial 
drugs to increase their efficacy. Finally, in a hypothetical antimicrobial therapy with EOs in 
combination with known antimicrobials, maximum benefit could be achieved using iso-
lated active components from each oil. Also dosing regimens of EOs, when in combination 
with reference antimicrobials, should be explored for higher therapeutic efficacy and to 
decrease toxicological profiles.
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